Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation. Evidence-based clinical science should guide FDA decision making about product labeling

Lee P. Shulman; Louise H. Bateman; Mitchell D Creinin; Vanessa E. Cullins; Lee Lee Doyle; Emily Godfrey; Patricia Murphy; Pablo Rodriguez; Scott J. Spear; Felicia H. Stewart; Michael A. Thomas; Carolyn L. Westhoff; Sandra Worthington

doi:10.1016/j.contraception.2006.01.007

Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation. Evidence-based clinical science should guide FDA decision making about product labeling

Lee P. Shulman, Louise H. Bateman, Mitchell D Creinin, Vanessa E. Cullins, Lee Lee Doyle, Emily Godfrey, Patricia Murphy, Pablo Rodriguez, Scott J. Spear, Felicia H. Stewart, Michael A. Thomas, Carolyn L. Westhoff, Sandra Worthington

Research output: Contribution to journal › Article

4 Scopus citations

Original language	English (US)
Pages (from-to)	440-442
Number of pages	3
Journal	Contraception
Volume	73
Issue number	5
DOIs	https://doi.org/10.1016/j.contraception.2006.01.007
State	Published - May 2006
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)
Obstetrics and Gynecology

Access to Document

10.1016/j.contraception.2006.01.007

Cite this

Shulman, L. P., Bateman, L. H., Creinin, M. D., Cullins, V. E., Doyle, L. L., Godfrey, E., Murphy, P., Rodriguez, P., Spear, S. J., Stewart, F. H., Thomas, M. A., Westhoff, C. L., & Worthington, S. (2006). Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation. Evidence-based clinical science should guide FDA decision making about product labeling. Contraception, 73(5), 440-442. https://doi.org/10.1016/j.contraception.2006.01.007

Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation. Evidence-based clinical science should guide FDA decision making about product labeling. / Shulman, Lee P.; Bateman, Louise H.; Creinin, Mitchell D; Cullins, Vanessa E.; Doyle, Lee Lee; Godfrey, Emily; Murphy, Patricia; Rodriguez, Pablo; Spear, Scott J.; Stewart, Felicia H.; Thomas, Michael A.; Westhoff, Carolyn L.; Worthington, Sandra.

In: Contraception, Vol. 73, No. 5, 05.2006, p. 440-442.

Research output: Contribution to journal › Article

Shulman, LP, Bateman, LH, Creinin, MD, Cullins, VE, Doyle, LL, Godfrey, E, Murphy, P, Rodriguez, P, Spear, SJ, Stewart, FH, Thomas, MA, Westhoff, CL & Worthington, S 2006, 'Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation. Evidence-based clinical science should guide FDA decision making about product labeling', Contraception, vol. 73, no. 5, pp. 440-442. https://doi.org/10.1016/j.contraception.2006.01.007

Shulman, Lee P. ; Bateman, Louise H. ; Creinin, Mitchell D ; Cullins, Vanessa E. ; Doyle, Lee Lee ; Godfrey, Emily ; Murphy, Patricia ; Rodriguez, Pablo ; Spear, Scott J. ; Stewart, Felicia H. ; Thomas, Michael A. ; Westhoff, Carolyn L. ; Worthington, Sandra. / Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation. Evidence-based clinical science should guide FDA decision making about product labeling. In: Contraception. 2006 ; Vol. 73, No. 5. pp. 440-442.

@article{1ae78f89050e45e6891fcb58fa5a8c49,

title = "Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation. Evidence-based clinical science should guide FDA decision making about product labeling",

author = "Shulman, {Lee P.} and Bateman, {Louise H.} and Creinin, {Mitchell D} and Cullins, {Vanessa E.} and Doyle, {Lee Lee} and Emily Godfrey and Patricia Murphy and Pablo Rodriguez and Spear, {Scott J.} and Stewart, {Felicia H.} and Thomas, {Michael A.} and Westhoff, {Carolyn L.} and Sandra Worthington",

year = "2006",

month = may,

doi = "10.1016/j.contraception.2006.01.007",

language = "English (US)",

volume = "73",

pages = "440--442",

journal = "Contraception",

issn = "0010-7824",

publisher = "Elsevier USA",

number = "5",

}

TY - JOUR

T1 - Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation. Evidence-based clinical science should guide FDA decision making about product labeling

AU - Shulman, Lee P.

AU - Bateman, Louise H.

AU - Creinin, Mitchell D

AU - Cullins, Vanessa E.

AU - Doyle, Lee Lee

AU - Godfrey, Emily

AU - Murphy, Patricia

AU - Rodriguez, Pablo

AU - Spear, Scott J.

AU - Stewart, Felicia H.

AU - Thomas, Michael A.

AU - Westhoff, Carolyn L.

AU - Worthington, Sandra

PY - 2006/5

Y1 - 2006/5

UR - http://www.scopus.com/inward/record.url?scp=33646057979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646057979&partnerID=8YFLogxK

U2 - 10.1016/j.contraception.2006.01.007

DO - 10.1016/j.contraception.2006.01.007

M3 - Article

C2 - 16627028

AN - SCOPUS:33646057979

VL - 73

SP - 440

EP - 442

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 5

ER -